US20190125228A1 - Structural diffusion membranes for chemical sensors - Google Patents
Structural diffusion membranes for chemical sensors Download PDFInfo
- Publication number
- US20190125228A1 US20190125228A1 US16/130,638 US201816130638A US2019125228A1 US 20190125228 A1 US20190125228 A1 US 20190125228A1 US 201816130638 A US201816130638 A US 201816130638A US 2019125228 A1 US2019125228 A1 US 2019125228A1
- Authority
- US
- United States
- Prior art keywords
- medical device
- implantable medical
- barrier layer
- structural reinforcing
- outer barrier
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000126 substance Substances 0.000 title claims abstract description 72
- 238000009792 diffusion process Methods 0.000 title description 5
- 239000012528 membrane Substances 0.000 title description 3
- 230000003014 reinforcing effect Effects 0.000 claims abstract description 96
- 230000004888 barrier function Effects 0.000 claims abstract description 78
- 239000011159 matrix material Substances 0.000 claims abstract description 9
- 210000001124 body fluid Anatomy 0.000 claims abstract description 8
- 239000000463 material Substances 0.000 claims description 62
- 230000003287 optical effect Effects 0.000 claims description 61
- 150000002500 ions Chemical class 0.000 claims description 36
- -1 polyethylene Polymers 0.000 claims description 26
- 238000001514 detection method Methods 0.000 claims description 25
- 230000005284 excitation Effects 0.000 claims description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 22
- 239000011521 glass Substances 0.000 claims description 22
- 239000005388 borosilicate glass Substances 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 19
- 239000000377 silicon dioxide Substances 0.000 claims description 11
- 239000004698 Polyethylene Substances 0.000 claims description 10
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims description 10
- 229920000573 polyethylene Polymers 0.000 claims description 10
- 239000010936 titanium Substances 0.000 claims description 10
- 229910052719 titanium Inorganic materials 0.000 claims description 10
- 239000004677 Nylon Substances 0.000 claims description 9
- 239000004743 Polypropylene Substances 0.000 claims description 9
- 239000004973 liquid crystal related substance Substances 0.000 claims description 9
- 229920001778 nylon Polymers 0.000 claims description 9
- 229920000728 polyester Polymers 0.000 claims description 9
- 229920001155 polypropylene Polymers 0.000 claims description 9
- 229920002635 polyurethane Polymers 0.000 claims description 9
- 239000004814 polyurethane Substances 0.000 claims description 9
- 229910052710 silicon Inorganic materials 0.000 claims description 9
- 239000010703 silicon Substances 0.000 claims description 9
- 229910001220 stainless steel Inorganic materials 0.000 claims description 9
- 239000010935 stainless steel Substances 0.000 claims description 9
- 229920001223 polyethylene glycol Polymers 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
- 229910052700 potassium Inorganic materials 0.000 claims description 6
- 239000011591 potassium Substances 0.000 claims description 6
- 229920000936 Agarose Polymers 0.000 claims description 5
- 102000008186 Collagen Human genes 0.000 claims description 5
- 108010035532 Collagen Proteins 0.000 claims description 5
- 108010010803 Gelatin Proteins 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 5
- 229920000615 alginic acid Polymers 0.000 claims description 5
- 235000010443 alginic acid Nutrition 0.000 claims description 5
- 229920001436 collagen Polymers 0.000 claims description 5
- 229920000159 gelatin Polymers 0.000 claims description 5
- 239000008273 gelatin Substances 0.000 claims description 5
- 235000019322 gelatine Nutrition 0.000 claims description 5
- 235000011852 gelatine desserts Nutrition 0.000 claims description 5
- 229910052744 lithium Inorganic materials 0.000 claims description 5
- 239000011777 magnesium Substances 0.000 claims description 5
- 229910052749 magnesium Inorganic materials 0.000 claims description 5
- 229920000058 polyacrylate Polymers 0.000 claims description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 5
- 229910052708 sodium Inorganic materials 0.000 claims description 5
- 239000011734 sodium Substances 0.000 claims description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 4
- 239000011575 calcium Substances 0.000 claims description 4
- 229910052791 calcium Inorganic materials 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-O oxonium Chemical compound [OH3+] XLYOFNOQVPJJNP-UHFFFAOYSA-O 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 3
- 230000008878 coupling Effects 0.000 claims description 3
- 238000010168 coupling process Methods 0.000 claims description 3
- 238000005859 coupling reaction Methods 0.000 claims description 3
- 101000585553 Homo sapiens Glycodelin Proteins 0.000 claims 2
- 239000012491 analyte Substances 0.000 abstract description 12
- 239000011324 bead Substances 0.000 description 19
- 229920000642 polymer Polymers 0.000 description 13
- 239000007864 aqueous solution Substances 0.000 description 12
- 230000000712 assembly Effects 0.000 description 11
- 238000000429 assembly Methods 0.000 description 11
- 229910001414 potassium ion Inorganic materials 0.000 description 11
- 239000013543 active substance Substances 0.000 description 9
- 239000000017 hydrogel Substances 0.000 description 8
- 230000000236 ionophoric effect Effects 0.000 description 8
- 230000000536 complexating effect Effects 0.000 description 7
- 239000002555 ionophore Substances 0.000 description 7
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 229940121363 anti-inflammatory agent Drugs 0.000 description 5
- 239000002260 anti-inflammatory agent Substances 0.000 description 5
- 239000000919 ceramic Substances 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000004891 communication Methods 0.000 description 5
- 229910001415 sodium ion Inorganic materials 0.000 description 5
- 239000008139 complexing agent Substances 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 3
- 230000002491 angiogenic effect Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 2
- 229920000690 Tyvek Polymers 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000012867 bioactive agent Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 229940126864 fibroblast growth factor Drugs 0.000 description 2
- 230000005669 field effect Effects 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- QNILTEGFHQSKFF-UHFFFAOYSA-N n-propan-2-ylprop-2-enamide Chemical compound CC(C)NC(=O)C=C QNILTEGFHQSKFF-UHFFFAOYSA-N 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 2
- 239000012780 transparent material Substances 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- VHRSUDSXCMQTMA-PJHHCJLFSA-N 6alpha-methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 229940122361 Bisphosphonate Drugs 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 239000004775 Tyvek Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001455 anti-clotting effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000002095 anti-migrative effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000002769 anti-restenotic effect Effects 0.000 description 1
- 230000002965 anti-thrombogenic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 229960005475 antiinfective agent Drugs 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 150000004663 bisphosphonates Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229940072645 coumadin Drugs 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 229940120889 dipyrone Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229940125721 immunosuppressive agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229960004752 ketorolac Drugs 0.000 description 1
- OZWKMVRBQXNZKK-UHFFFAOYSA-N ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 229960004584 methylprednisolone Drugs 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- SBIBMFFZSBJNJF-UHFFFAOYSA-N selenium;zinc Chemical compound [Se]=[Zn] SBIBMFFZSBJNJF-UHFFFAOYSA-N 0.000 description 1
- 210000004911 serous fluid Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
- A61B5/14735—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter comprising an immobilised reagent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/16—Details of sensor housings or probes; Details of structural supports for sensors
- A61B2562/162—Capsule shaped sensor housings, e.g. for swallowing or implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
Definitions
- Embodiments herein relate to implantable chemical sensors for detecting a physiological analyte and medical devices including the same.
- Implanted chemical sensors offer the promise of being able to gather data on analyte concentrations in real time even while a patient is away from a medical treatment facility.
- implanted chemical sensors can measure analyte concentrations from the interstitial fluid as the analyte passes through a soft hydrophilic diffusion membrane and into a chemical sensor. The measurements can occur continuously or semi-continuously providing a far richer data set for a medical professional to evaluate.
- an implantable medical device in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, an implantable medical device is included.
- the implantable medical device can include a chemical sensor configured to detect an ion concentration in a bodily fluid.
- the chemical sensor can include a sensing element.
- the sensing element can include an outer barrier layer forming a top, a bottom, and opposed sides of the sensing element and a structural reinforcing element contacting the outer barrier layer.
- the top of the outer barrier layer of the sensing element can include a polymeric matrix permeable to analytes.
- a structural reinforcing element can be disposed beneath, within, or on top of the top of the outer barrier layer.
- a structural reinforcing element in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, can be formed of polyester, polyurethane, polyethylene, polypropylene, nylon, sintered titanium, deep reactive-ion etched silicon, sintered stainless steel, sintered silica, liquid crystal, glass, borosilicate glass, or mixtures or derivatives thereof.
- a structural reinforcing element in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, can be formed of a woven material.
- a structural reinforcing element in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, can include one or more intramural struts spanning a distance between the top and the bottom of the outer barrier layer.
- the one or more intramural struts can be formed of polyester, polyurethane, polyethylene, polypropylene, nylon, sintered titanium, deep reactive-ion etched silicon, sintered stainless steel, sintered silica, liquid crystal, glass, borosilicate glass, or mixtures or derivatives thereof.
- an outer barrier layer can be formed of polyHEMA, agarose, alginates, polyvinyl alcohol, polyacrylate, collagen, PEG, gelatin, glass, borosilicate glass, or mixtures or derivatives thereof.
- the implantable medical device can include an optical excitation assembly configured to illuminate the sensing element; and an optical detection assembly configured to receive light from the sensing element.
- a chemical sensor in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, can have a diameter that is greater than 1.0 mm.
- a chemical sensor in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, can be configured to detect an ion selected from the group consisting of potassium, sodium, chloride, calcium, magnesium, lithium, or hydronium.
- an implantable medical device in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, is included.
- the implantable medical device can include a chemical sensor configured to detect an ion concentration in a bodily fluid.
- the chemical sensor can include a sensing element.
- the sensing element can include an outer barrier layer forming a top, a bottom, and opposed sides of the sensing element, where the outer barrier layer defines an interior volume.
- the sensing element can also include a structural reinforcing element disposed within the interior volume, where the structural reinforcing element is porous.
- a structural reinforcing element in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, can fill at least between 10% to 25% of the interior volume.
- a structural reinforcing element in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, can be formed of a polyester, polyurethane, polyethylene, polypropylene, nylon, sintered titanium, deep reactive-ion etched silicon, sintered stainless steel, sintered silica, liquid crystal, glass, borosilicate glass, or mixtures or derivatives thereof.
- a structural reinforcing element in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, can be formed of a borosilicate glass.
- an outer barrier layer can be formed of polyHEMA, agarose, alginates, polyvinyl alcohol, polyacrylate, collagen, PEG, gelatin, glass, borosilicate glass, or mixtures or derivatives thereof.
- an outer barrier layer can be formed of a glass.
- an outer barrier layer can be formed of a borosilicate glass.
- the bottom of an outer barrier layer can include a glass interface plate for coupling the sensing element to an optical excitation assembly and an optical detection assembly.
- the top of the outer barrier layer can be formed of polyHEMA.
- a structural reinforcing element in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, can be infused with one or more ion selective sensors.
- FIG. 1 is a schematic top view of an implantable medical device in accordance with the embodiments herein.
- FIG. 2 is a cross-sectional view of a chemical sensor taken along line 2 - 2 ′ of FIG. 1 .
- FIG. 3 is a schematic plan view of a structural reinforcing element in accordance with various embodiments herein.
- FIG. 4 is a schematic plan view of a structural reinforcing element in accordance with various embodiments herein.
- FIG. 5 is a cross-sectional view of a chemical sensor in accordance with additional embodiments herein.
- FIG. 6 is a cross-sectional view of a chemical sensor in accordance with additional embodiments herein.
- FIG. 7 is a cross-sectional view of a chemical sensor in accordance with additional embodiments herein.
- FIG. 8 is a cross-sectional view of a chemical sensor in accordance with additional embodiments herein.
- FIG. 9 is a schematic top view of an implantable medical device in accordance with additional embodiments herein.
- FIG. 10 is a schematic cross-sectional view of a sensing element in accordance with additional embodiments herein.
- FIG. 11 is a schematic cross-sectional view of an implantable medical device in accordance with various embodiments herein.
- FIG. 12 is a schematic diagram of components of an implantable medical device in accordance with various embodiments herein.
- Implanted chemical sensors offer the promise of being able to gather data on analyte concentrations in real time even while a patient is away from a medical treatment facility.
- Highly-porous soft hydrophilic polymers are ideal materials for use with implanted chemical sensors because of their ability to permit the rapid transport of large amounts of analytes across sensor walls and thus contribute to rapid response times for sensors built using the same.
- many such materials lack desirable levels of structural integrity.
- Such materials are generally soft and flexible which can lead to challenges when designing sensor elements, especially as the sensors get larger.
- the use of such materials in a chemical sensor can resulting in undesirable deformation and/or structural failure and interference at the optical interface of the chemical sensor, which can lead to diminished response and/or loss of function of the chemical sensor.
- Embodiments herein can include structural reinforcing elements that can provide structural integrity to soft hydrophilic diffusion membranes of chemical sensors.
- structural reinforcing elements can maintain their structural integrity over the lifetime of the sensor.
- the IMD 100 can include an implantable housing 102 and a header 104 coupled to the implantable housing 102 .
- the housing 102 can be formed of a material such as a metal, ceramic, a polymer, or a composite.
- the header 104 can be formed of various materials, but in some embodiments the header 104 can be formed of a transparent or translucent polymer such as an epoxy material. In some embodiments the header 104 can be hollow. In other embodiments the header 104 can be filled with components and/or structural materials such as epoxy or another material such that it is non-hollow.
- the IMD 100 can also include a chemical sensor 106 coupled to the implantable housing 102 .
- Chemical sensor 106 can be configured to detect an ion concentration of a bodily fluid when implanted in the body.
- the chemical sensor 106 can be configured to detect an ion selected from the group consisting of potassium, sodium, chloride, calcium, magnesium, lithium, hydronium, hydrogen phosphate, bicarbonate, and the like.
- Bodily fluids can include blood, interstitial fluid, serum, lymph, serous fluid, cerebrospinal fluid, and the like.
- chemical sensor 106 can be configured to detect one or more of an electrolyte, a protein, a sugar, a hormone, a peptide, an amino acid, and a metabolic product. However, many other analytes are also contemplated herein.
- chemical sensor 106 can be positioned at any location along IMD 100 , including a location along the implantable housing 102 and a location along the header 104 .
- the IMD 100 can take on various dimensions. In a particular embodiment herein it can be approximately 2 to 3 inches in length, 0.4 to 0.6 inches wide, and 0.15 to 0.35 inches thick. However, in some embodiments, the IMD 100 can be about 0.25, 0.5, 1.0, 2.0, 3.0, 4.0, or 5.0 inches in length. In some embodiments the length can be in a range wherein any of the foregoing lengths can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound.
- the IMD 100 can be about 0.25, 0.5, 0.75, 1.0, or 2.0 inches in width. In some embodiments the length can be in a range wherein any of the foregoing widths can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound. In some embodiments, the IMD 100 can be about 0.10, 0.25, 0.50, 0.75 or 1.0 inches thick. In some embodiments the thickness can be in a range wherein any of the foregoing thicknesses can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound.
- the chemical sensor 106 can be in the shape of a circle.
- the diameter of the chemical sensor 106 can be about 0.5 mm, 0.75 mm, 1.0 mm, 1.5 mm, 1.75 mm, 2.0 mm, 2.5 mm, 2.75 mm, 3.0 mm, 3.25 mm, 3.5 mm, 3.75 mm, 4.0 mm, 4.5 mm, or 5.0 mm.
- the diameter can be in a range wherein any of the foregoing diameters can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound.
- the diameter of the chemical sensor 106 is greater than or equal to 1.5 mm. Though chemical sensor 106 is depicted in FIG.
- chemical sensor 106 can assume a variety of shapes, including but not limited to a square, a rectangle, a triangle, a trapezoid, an oval, and the like. It will also be appreciated that IMD 100 can include one or more chemical sensors that measure the same, or different analytes. In some embodiments, one or more chemical sensors can be arranged as an array in a variety of shapes, such as, for example, a grid, a circle, a mosaic, a geometric patter, or the like.
- the height (depth) of the chemical sensor 106 can be about 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.75 mm, 1.0 mm, 1.5 mm, 1.75 mm, 2.0 mm, 2.5 mm, 2.75 mm, 3.0 mm, 3.25 mm, 3.5 mm, 3.75 mm, 4.0 mm, 4.5 mm, or 5.0 mm, 6 mm, 7 mm, 8 mm, 9 mm, or 10 mm.
- the height of the chemical sensor 106 can be in a range wherein any of the foregoing distances can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound.
- Chemical sensor 106 can include, but not be limited to, sensing element 202 , optical excitation assembly 218 , and optical detection assembly 220 .
- FIG. 3 shows an optical chemical sensor.
- the chemical sensor can be a potentiometric chemical sensor.
- the sensing element 202 can include an outer barrier layer 204 formed, in full or in part, from a permeable material, such as an ion permeable polymeric matrix material, and the like. Exemplary materials for the outer barrier layer 204 are described in greater detail below.
- Outer barrier layer 204 can form a top 205 , a bottom 210 , and opposed sides 206 and 208 to surround an interior volume 222 of sensing element 202 .
- Bottom 210 and opposed sides 206 and 208 of outer barrier layer 204 will be discussed in more detail below in reference to FIGS. 3-5 . Briefly, however, they can be formed of the same material as the top 205 , or they can be formed from a different material.
- At least the top 205 of outer barrier layer 204 can be permeable to sodium ions, potassium ions, hydronium ions, creatinine, urea, and the like.
- Outer barrier layer 204 can also include an active agent disposed therein including, but not limited to anti-inflammatory agents, angiogenic agents, and the like. Exemplary active agents are described in greater detail below.
- bottom 210 may or may not be a discrete layer.
- bottom 210 and a transparent member 216 within a recessed pan 214 of the implantable housing 102 may be combined with different material or combined as one layer with same type of material.
- the outer barrier layer 204 can include a structural reinforcing element 212 disposed within, on or under the outer surface of the outer barrier layer 204 .
- the structural reinforcing element 212 can be disposed within, on top of, or beneath the outer barrier layer 204 .
- the structural reinforcing element 212 can be disposed within, on or under the exterior surface of opposed sides 206 and 208 .
- structural reinforcing element 212 can be disposed within, on or under the outer surface of bottom 210 of the outer barrier layer 204 .
- the structural reinforcing element 212 can be disposed within, on or under the outer surface of the entire outer barrier layer 204 .
- the structural reinforcing element will be further discussed in reference to FIGS. 3-5 below. It will be appreciated that the structural reinforcing elements embodied herein can take on many shapes and forms in accordance with additional embodiments herein.
- the structural reinforcing elements can come in various shapes and sizes.
- the structural reinforcing elements can be columnar, pyramidal, frustopyramidal, conical, frustoconical, cylindrical, rectangular, and the like.
- the base of the structural reinforcing element can have a greater width than the top of the structural reinforcing element.
- the top of the structural reinforcing element can have a greater width than the bottom of the structural reinforcing element.
- the top and the bottom of the structural reinforcing element can have the same width.
- the height of the structural reinforcing elements can be about 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.75 mm, 1.0 mm, 1.5 mm, 1.75 mm, 2.0 mm, 2.5 mm, 2.75 mm, 3.0 mm, 3.25 mm, 3.5 mm, 3.75 mm, 4.0 mm, 4.5 mm, or 5.0 mm, 6 mm, 7 mm, 8 mm, 9 mm, or 10 mm.
- the height of the structural reinforcing elements can be in a range wherein any of the foregoing diameters can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound.
- the structural reinforcing elements can be positioned in various places within the sensing element. In some embodiments, there can be multiple structural reinforcing elements and they can be spaced out across the sensing element (such as spaced out across the width of the chemical sensor along X and/or Y axes, wherein the depth of the chemical sensor would be the Z axis). In some embodiments, multiple structural reinforcing elements can be evenly spaced out. In some embodiments, multiple structural reinforcing elements can spaced from each other, but with a bias toward the middle of the diameter of the chemical sensor, such that a central portion (such as a central 50% of the overall diameter) has a higher density of structural reinforcing elements.
- Materials suitable for forming the structural reinforcing elements discussed herein can include, but not be limited to, porous rigid polymers, porous rigid ceramics, polyester, polyurethane, polyethylene, polypropylene, nylon, sintered titanium, deep reactive-ion etched silicon, sintered stainless steel, sintered silica, liquid crystal, glass, silica-containing glass, borosilicate glass such as but not limited to VYCOR®, or mixtures or derivatives thereof.
- Structural reinforcing elements will be discussed in more detail below.
- the implantable housing 102 can include a recessed pan 214 into which the sensing element 202 fits.
- the top of the recessed pan 214 can be substantially flush with the top of the sensing element 202 .
- implantable housing 102 can define an aperture occluded by a transparent member 216 .
- the transparent member 216 can be a glass (including but not limited to borosilicate glasses), a polymer or other transparent material.
- the aperture can be disposed at the bottom of the recessed pan 214 .
- the aperture can provide an interface allowing for optical communication between sensing element 202 and the optical excitation 218 and optical detection 220 assemblies.
- the bottom 210 of the outer barrier layer 204 can be combined with the transparent member 216 .
- Bottom 210 and transparent member 216 may be combined with different material or combined as one layer with same type of material.
- outer barrier layer 204 can be made from a transparent polymer matrix material to allow for optical communication between the sensing element 202 and optical excitation 218 and optical detection 220 assemblies.
- the optical excitation assembly 218 can be configured to illuminate the sensing element 202 .
- Optical excitation assembly 218 can include a light source such as a light emitting diode (LED), vertical-cavity surface-emitting lasers (VCSELs), electroluminescent (EL) devices, and the like.
- Optical detection assembly 220 can include a component selected from the group consisting of a photodiode, a phototransistor, a charge-coupled device (CCD), a junction field effect transistor (JFET) optical sensor, a complementary metal-oxide semiconductor (CMOS) optical sensor, an integrated photo detector integrated circuit, a light to voltage converter, and the like.
- CMOS complementary metal-oxide semiconductor
- FIG. 3 a schematic plan view is shown of a structural reinforcing element 212 in accordance with various embodiments herein.
- the structural reinforcing element 212 can take on many different shapes including but not limited to a square, a rectangle, a triangle, a trapezoid, an oval, and the like.
- the structural reinforcing element 212 is solid, but porous. However, it will be appreciated that in some embodiments, the structural reinforcing element 212 can be formed of a non-porous material. Further, in some embodiments, the structural reinforcing element can include one or more apertures disposed therein. Referring now to FIG. 4 a schematic plan view is shown of a structural reinforcing element 212 in accordance with various embodiments herein. As can be seen, the structural reinforcing element 212 includes apertures 402 .
- sensing element 202 is shown in accordance with various embodiments herein.
- sensing element 202 can include an outer barrier layer 204 .
- Outer barrier layer 204 can form a top 205 , a bottom 210 , and opposed sides 206 and 208 to surround an interior volume 222 of sensing element 202 .
- Outer barrier layer 204 can also include a structural reinforcing element 212 .
- FIG. 5 shows a sensing element 202 having an outer barrier layer 204 , the outer barrier layer including a top 205 , a bottom 210 , and opposing sides 206 and 208 , the entirety of which can be formed from a material permeable to sodium ions, potassium ions, and hydronium ions, and the like. Materials suitable for use in the outer barrier layer 204 are discussed further below.
- the sensing element 202 can include one or more intramural struts 306 spanning a distance between the top 205 and the bottom 210 of the outer barrier layer 204 .
- the one or more intramural struts 506 can include a structural reinforcing element 212 disposed within, on or under the outer surface of the intramural struts 506 .
- Materials suitable for forming the structural reinforcing element 212 of the one or more intramural struts 506 can include, but not be limited to rigid porous polymers, rigid porous ceramics, polyester, polyurethane, polyethylene, polypropylene, nylon, sintered titanium, deep reactive-ion etched silicon, sintered stainless steel, sintered silica, liquid crystal, glass, borosilicate glass, or mixtures or derivatives thereof.
- the intramural struts 306 can have a larger size or diameter on the side that contacts the bottom 210 in comparison to the size of the intramural struts that contacts the top 205 . However, the reverse may also be true, such as shown in FIG. 6 described below. In some embodiments, the intramural struts 306 can be circular, oval, square, or polygonal in cross-section.
- the length of the struts can depend on the size of the sensing element, but in some embodiments can be 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1 mm, 2 mm, 3 mm, 4 mm, 5 mm, 7 mm, 9 mm, 11 mm, 13 mm, 15 mm, 20 mm, or 30 mm; or can fall within a range between any of the foregoing distances.
- the number of struts can vary. The number of struts used can be 1, 2, 3, 4, 5, 7, 9, 11, 13, 15, 20, 25, 30, 40, 50, 60, 80, 100 or more. In some embodiments, the number of struts can fall within a range between any of the foregoing.
- the sensing element(s) 202 embodied herein can include an interior volume 222 and can also include disposed therein various indicator beads for detecting an ion concentration of a bodily fluid when implanted in the body.
- FIG. 5 shows a first indicator bead 502 and a second indicator bead 504 .
- the first and second indicator beads 502 and 504 can include a polymeric support material and one or more ion selective sensors as described more fully below.
- Physiological analytes such as potassium ion, sodium ion, hydronium ion, and the like, can diffuse through the top 205 of the outer barrier layer 204 , and where present, the structural reinforcing element 212 , and onto and/or into first and second indicator beads 502 and 504 where they can bind with the ion selective sensors to produce a fluorimetric or colorimetric response.
- the first indicator beads 502 can be segregated to one side of the interior volume 222 , with or without an interior divider.
- the second indicator beads 504 can be segregated to a different side of the interior volume than the first indicator beads 502 .
- the first indicator beads 502 and second indicator beads 504 can be designed to detect the same analyte.
- the first indicator beads 502 and second indicator beads 504 can be designed to detect the different analytes.
- the first indicator beads 502 and the second indicator beads 504 can be separated out by having two individual outer barrier layers 204 .
- the two sets of beads can be spaced out by a certain distance, such as at least about 0.1, 0.2, 0.3, 0.4, 0.5, 1, 2, 3, 5, 10 or 15 millimeters and less than 100, 70, 50, 40, 30, or 20 millimeters.
- top 205 In some embodiments additional diffusion of physiological analytes is also possible through bottom 210 , opposing sides 206 and 208 , and, where present, the structural reinforcing element 212 .
- FIG. 5 shows discrete indicator beads, it will be appreciated that the indicator components can also exist in other forms such as a single larger combined mass, an infusion, or the like, as will be discussed with respect to FIGS. 7 and 8 .
- the sensing element(s) 202 embodied herein can include an aqueous solution 508 disposed within the interior volume 222 .
- the aqueous solution 508 can include potassium ions at a concentration of about 3.0 to about 6.0 mmol/L.
- the aqueous solution 508 can include potassium ions at a concentration of about 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, or 8.0 mmol/L.
- the concentration of potassium ions in the aqueous solution 508 can be in a range between any of the foregoing multiples provided that the upper bound of the range is greater than the lower bound of the range.
- the aqueous solution 508 can surround the exterior of sensing element 202 during packaging and prior to use, as discussed below in reference to FIG. 10 .
- sensing element 202 is shown having an outer barrier layer 204 , the outer barrier layer including a top 205 , a bottom 210 , and opposing sides 206 and 208 , the entirety of which can be formed from a polymeric matrix permeable to sodium ions, potassium ions, and hydronium ions, and the like.
- Permeable materials suitable for use in the outer barrier layer 204 are discussed further below.
- FIG. 5 shows a structural reinforcing element 212 disposed within the interior volume 222 of sensing element 202 .
- the structural reinforcing element 212 can be created from a porous material.
- the structural reinforcing element 212 can fill at least 5%, 10%, 15%, 20%, 25%, 30%, 40%, or 50% of the interior volume 222 of sensing element 202 .
- the structural reinforcing element 212 can fill an interior volume falling within a range, wherein any of the forgoing percentages can serve as the lower or upper bound of the range, provided that the lower bound of the range is a value less than the upper bound of the range.
- the structural reinforcing element 212 disposed within interior volume 222 can be infused with one or more ion selective sensors, which are described more fully below.
- FIG. 6 shows a structural reinforcing element 212 disposed within the interior volume 222 of sensing element 202 .
- the structural reinforcing element 212 can be created from a porous material.
- the structural reinforcing element 212 can fill at least 5%, 10%, 15%, 20%, 25%, 30%, 40%, or 50% of the interior volume 222 of sensing element 202 .
- the structural reinforcing element 212 disposed within interior volume 222 can be infused with one or more ion selective sensors, which are described more fully below.
- the structural reinforcing element 212 can include one or more intramural struts 506 .
- FIG. 7 shows a sensing element 202 having an outer barrier layer 204 where the top 205 , and opposing sides 206 and 208 are formed from the same material that is permeable to sodium ions, potassium ions, and hydronium ions, and the like.
- the bottom 210 is shown having a different material composition. It will be appreciated that bottom 210 of outer barrier layer 204 can be formed of a transparent material to couple the sensing element 202 to the optical excitation 218 and optical detection 220 assemblies. Coupling the sensing element 202 to the optical excitation 218 and optical detection 220 assemblies can facilitate optical communication between the two structures.
- the bottom can be formed from a different material than the outer barrier layer.
- FIG. 8 another cross-sectional view of a chemical sensor is shown in accordance with some embodiments.
- the bottom 210 can be formed from a glass, such as a borosilicate glass.
- the bottom 210 can be formed from transparent polymeric materials.
- bottom 210 can be fused to an implantable housing at the interface with a transparent member, as discussed above.
- Implantable medical device 900 can include an implantable housing 102 coupled to a header 104 .
- the chemical sensor 106 is shown coupled to the header 104 . It will be appreciated that more than one chemical sensor can be included in the header 104 of medical device 900 .
- seal 1002 can provide a tight seal between the external environment and the chemical sensor 106 when packaged.
- seal 1002 can provide an effective barrier to keep aqueous solution 308 within recessed pan 214 such that the sensing element 202 can be constantly bathed in aqueous solution 308 prior to implant.
- the aqueous solution 308 present in recessed pan 214 can also include potassium ions at a concentration of about 3.0 to about 6.0 mmol/L. In some embodiments, the aqueous solution 308 can include potassium ions at a concentration of about 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, or 8.0 mmol/L. In some embodiments, the concentration of potassium ions in the aqueous solution 308 can be in a range between any of the foregoing amounts provided that the upper bound of the range is greater than the lower bound of the range.
- Seal 1002 can be removed from the chemical sensor 106 by a medical professional just prior to implantation.
- seal 1002 can be non-porous to the passage of aqueous solutions.
- seal 1002 can be made from a polymer such as polyethylene terephthalate (PET), polytetrafluoroethylene (PTFE), polyethylene, polystyrene, and the like.
- PET polyethylene terephthalate
- PTFE polytetrafluoroethylene
- the seal 1002 can be made from a foil, such as a metal foil.
- the seal 1002 can be made from a radiopaque material.
- the IMD 100 can include implantable housing 102 .
- the implantable housing 102 of IMD 100 can include various materials such as metals, polymers, ceramics, and the like.
- the implantable housing 102 can be a single integrated unit.
- the implantable housing 102 can include implantable housing 102 and epoxy header 104 , as discussed above.
- the implantable housing 102 or one or more portions thereof, can be formed of titanium.
- one or more segments of the implantable housing 102 can be hermetically sealed.
- Implantable housing 102 can define an interior volume 804 that in some embodiments is hermetically sealed off from the area 1106 outside of IMD 100 .
- the IMD 100 can include circuitry 1108 .
- Circuitry 1108 can include various components, such as components 1110 , 1112 , 1114 , 1116 , 1118 , and 1120 . In some embodiments, these components can be integrated and in other embodiments these components can be separate. In some embodiments, the components can include one or more of a microprocessor, memory circuitry (such as random access memory (RAM) and/or read only memory (ROM)), recorder circuitry, telemetry circuitry, chemical sensor interface circuitry, power supply circuitry (which can include one or more batteries), normalization circuitry, chemical sensor control circuitry, and the like.
- RAM random access memory
- ROM read only memory
- recorder circuitry can record the data produced by the chemical sensor and record time stamps regarding the same.
- the circuitry can be hardwired to execute various functions, while in other embodiments the circuitry can be implemented as instructions executing on a microprocessor or other computation device.
- a telemetry interface 1122 can be provided for communicating with external devices such as a programmer, a home-based unit, and/or a mobile unit (e.g., a cellular phone, portable computer, etc.).
- telemetry interface 1122 can be provided for communicating with implanted devices such as a therapy delivery device (e.g. a pacemaker, cardioverter-defibrillator) or monitoring-only device (e.g. an implantable loop recorder).
- the circuitry can be implemented remotely, via either near-field, far-field, conducted, intra-body or extracorporeal communication, from instructions executing on any of the external or the implanted devices, etc.
- the telemetry interface 1122 can be located within implantable housing 102 .
- the telemetry interface 1122 can be located in header 104 .
- the optical excitation 218 and optical detection 220 assemblies of the chemical sensor 106 can be in electrical communication with the circuitry 1108 within the interior volume 1104 .
- the control circuitry 1108 is configured to selectively activate the optical excitation 218 and optical detection 220 assemblies of the chemical sensor 106 .
- IMD 100 can gather information through one or more sensing channels.
- a microprocessor 1202 can communicate with a memory 1204 via a bidirectional data bus.
- the memory 1204 can include read only memory (ROM) or random access memory (RAM) for program storage and RAM for data storage, or any combination thereof.
- the implantable medical device can also include one or more chemical sensors 106 and one or more chemical sensor channel interfaces 1206 which can communicate with a port of microprocessor 1202 .
- the chemical sensor channel interface 1206 can include various components such as analog-to-digital converters for digitizing signal inputs, sensing amplifiers, registers which can be written to by the control circuitry in order to adjust the gain and threshold values for the sensing amplifiers, source drivers, modulators, demodulators, multiplexers, and the like.
- a telemetry interface 1122 is also provided for communicating with external devices such as a programmer, a home-based unit, and/or a mobile unit (e.g., a cellular phone, portable computer, etc.), implanted devices such as a pacemaker, cardioverter-defibrillator, loop recorder, and the like.
- the outer barrier layer of the sensing element can be formed of a permeable material.
- the outer barrier layer can be formed from an ion-permeable polymeric matrix material.
- Suitable polymers for use as the ion-permeable polymeric matrix material can include, but are not limited to polymers forming a hydrogel.
- Hydrogels herein can include homopolymeric hydrogels, copolymeric hydrogels, and multipolymer interpenetrating polymeric hydrogels. Hydrogels herein can specifically include nonionic hydrogels.
- hydrogels herein can be prepared from polymerization of various monomers or macromers including one or more of poly 2-hydroxyethyl methacrylate (polyHEMA), 2-hydroxypropyl methacrylate (HPMA), acrylamide, acrylic acid, N-isopropylacrylamide (NIPAm), methoxyl polyethylene glycol monoacrylate (PEGMA), and the like.
- polymers can include, but are not limited to polyhydroxyethyl methacrylate (HEMA), cellulose, polyvinyl alcohol, polyacrylate, dextran, polyacrylamides, polyhydroxyalkyl acrylates, polyvinyl pyrrolidones, and mixtures and copolymers thereof.
- suitable polymers for use with the ion-permeable polymeric matrix described herein include those that are transparent.
- the outer barrier layer can be formed from porous materials such as, agarose, alginates, collagen, polyethylene glycol (PEG), gelatin, glass, borosilicate glass, or mixtures or derivatives thereof.
- the outer barrier layer is formed from glass.
- the outer barrier layer is formed from borosilicate glass.
- the outer barrier layer of the sensing element can include a structural reinforcing element disposed within the outer barrier layer.
- the structural reinforcing element can be disposed on the outer or inner surfaces of the outer barrier layer.
- the structural reinforcing element can be formed from an ion-permeable material. In other embodiments, the structural reinforcing element can be formed form a non-permeable material.
- Materials suitable for use with the structural reinforcing elements herein can include polyesters, such as polyethylene terephthalate (e.g., Dacron®); polyurethanes, including but not limited to Tecothane® aromatic polyether-based thermoplastic polyurethanes (TPUs); polyethylene; polypropylene; nylon; silk; polymethylmethacrylate (PMMA); sintered titanium; deep reactive-ion etched silicon; sintered stainless steel; sintered silica; liquid crystal; alumina; ceramic; glass; borosilicate glass; and the like.
- polyesters such as polyethylene terephthalate (e.g., Dacron®); polyurethanes, including but not limited to Tecothane® aromatic polyether-based thermoplastic polyurethanes (TPUs); polyethylene; polypropylene; nylon; silk; polymethylmethacrylate (PMMA); sintered titanium; deep reactive-ion etched silicon; sintered stainless steel; sintered silica; liquid crystal; alumina; ceramic; glass; boro
- the structural reinforcing element can exhibit a stiffness greater than the material of the outer barrier.
- the structural reinforcing element can be about 10, 20, 30, 40, 50, 60, 80, 100, 150, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1500, 2000, or 2500 percent stiffer than the outer barrier layer material.
- the structural reinforcing element can greater than 3000 percent stiffer than the outer barrier layer material.
- the structural reinforcing element can exhibit rigidity greater than the material of the outer barrier. In some embodiments, the structural reinforcing element can be about 10, 20, 30, 40, 50, 60, 80, 100, 150, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1500, 2000, or 2500 percent more rigid than the outer barrier layer material.
- the structural reinforcing element can exhibit greater tensile strength than the material of the outer barrier. In some embodiments, the structural reinforcing element can exhibit about 10, 20, 30, 40, 50, 60, 80, 100, 150, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1500, 2000, or 2500 percent more tensile strength than the outer barrier layer material.
- the structural reinforcing element can include a woven material.
- the structural reinforcing element can include a woven material made from an ion-permeable polymeric material.
- the structural reinforcing element can include a woven material made from a non-permeable material.
- the woven material can include a uniform weave pattern of fibers throughout the entirety of the structural reinforcing element.
- the woven material can include a non-uniform weave pattern of fibers throughout the entirety of the structural reinforcing element.
- the woven material can include oriented weave patterns.
- the structural reinforcing element can include a non-woven material having a non-uniform weave pattern of fibers throughout the entirety of the structural reinforcing element.
- a non-woven material is Tyvek®, which is made from high-density polyethylene fibers.
- the structural reinforcing element can include an electrospun polymeric material.
- the electrospun polymeric material can include a randomly woven polymeric material.
- the structural reinforcing element can be formed into a one-piece molded unit that can be infused with one or more ion selective sensors.
- sensing elements 202 can include one or more ion selective sensors included within one or more types of indicator beads, or infused within the structural reinforcing elements as described herein.
- Ion selective sensors may either rely on surface phenomena or on concentration changes inside the bulk of a phase.
- Ion selective sensors can include optical sensors, including both non-carrier optical sensors and carrier-based optical sensors, and ion-selective electrodes (ISEs).
- the ion selective sensor is fluorimetric, and can include a complexing moiety and a fluorescing moiety. Fluorimetric ion selective sensors can exhibit differential fluorescent intensity based upon the complexing of an analyte to a complexing moiety.
- the ion selective sensor can be colorimetric, and can include a complexing moiety and a colorimetric moiety. Colorimetric ion selective sensors can exhibit differential light absorbance based upon the complexing of an analyte to a complexing moiety.
- the ion selective sensor comprises a non-carrier or carrier-based fluorescent or colorimetric ionophoric composition that comprises a complexing moiety for reversibly binding an ion to be analyzed, and a fluorescing or colorimetric moiety that changes its optical properties as the complexing agent binds or releases the ion.
- the complexing agents of the invention can optionally be appended with one or more organic substituents chosen to confer desired properties useful in formulating the ion sensing composition.
- the substituents can be selected to stabilize the complexing agent with respect to leaching into the solution to be sensed, for example, by incorporating a hydrophobic or polymeric tail or by providing a means for covalent attachment of the complexing agent to a polymer support within the ion selective sensor.
- the sensing element can include ion selective sensors such as an ionophore or a fluoroionophore.
- Suitable ionophores for use with the embodiments herein can include, but not be limited to, sodium specific ionophores, potassium specific ionophores, calcium specific ionophores, magnesium specific ionophores, and lithium specific ionophores.
- Suitable fluoroionophores for use with the embodiments herein can include, but not be limited to, lithium specific fluoroionophores, sodium specific fluoroionophores, and potassium specific fluoroionophores.
- the optical excitation assembly 218 can include solid state light sources such as GaAs, GaAlAs, GaAlAsP, GaAlP, GaAsP, GaP, GaN, InGaAlP, InGaN, ZnSe, or SiC light emitting diodes or laser diodes that excite the sensing element(s) 202 at or near the wavelength of maximum absorption for a time sufficient to emit a return signal.
- solid state light sources such as GaAs, GaAlAs, GaAlAsP, GaAlP, GaAsP, GaP, GaN, InGaAlP, InGaN, ZnSe, or SiC light emitting diodes or laser diodes that excite the sensing element(s) 202 at or near the wavelength of maximum absorption for a time sufficient to emit a return signal.
- the wavelength of maximum absorption/reflection varies as a function of concentration in the colorimetric sensor.
- the optical excitation assembly 218 can include other light emitting components including incandescent components. In some embodiments, the optical excitation assembly 218 can include a waveguide. The optical excitation assembly 218 can also include one or more bandpass filters, high pass filter, low pass filter, antireflection elements, and/or focusing optics.
- the optical excitation assembly 218 can include a plurality of LEDs with bandpass filters, each of the LED-filter combinations emitting at a different center frequency.
- the LEDs can operate at different center-frequencies, sequentially turning on and off during a measurement, illuminating the sensing element 202 .
- a single unfiltered detector can be used in some embodiments.
- a polychromatic source can be used with multiple detectors that are each bandpass filtered to a particular center frequency.
- the sensing element 202 can include one or more types of indicator beads having embedded therein various types of ion selective sensors, described below.
- Physiological analytes of interest can diffuse into and out of the sensing element 202 and bind with an ion selective sensor to result in a fluorimetric or colorimetric response.
- Reference analytes can similarly diffuse into and out of the sensing element 202 and serve as a control sample. Exemplary ion selective sensors are described more fully below.
- the optical detection assembly 220 can be configured to receive light from the sensing element 202 .
- the optical detection assembly 220 can include a component to receive light.
- the optical detection assembly 220 can include a charge-coupled device (CCD).
- the optical detection assembly 220 can include a photodiode, a junction field effect transistor (JFET) type optical sensor, or a complementary metal-oxide semiconductor (CMOS) type optical sensor.
- the optical detection assembly 220 can include an array of optical sensing components.
- the optical detection assembly 220 can include a waveguide.
- the optical detection assembly 220 can also include one or more bandpass filters and/or focusing optics.
- the optical detection assembly 220 can include one or more photodiode detectors, each with an optical bandpass filter tuned to a specific wavelength range.
- the optical excitation and detection assemblies, 218 and 220 can be integrated using bifurcated fiber-optics that direct excitation light from a light source to one or more sensing elements 202 , or simultaneously to sensing element(s) 202 and a reference channel. Return fibers can direct emission signals from the sensing element(s) 202 and the reference channels to one or more optical detection assemblies 220 for analysis by a processor, such as a microprocessor.
- the optical excitation and detection assemblies are integrated using a beam-splitter assembly and focusing optical lenses that direct excitation light from a light source to the sensing element and direct emitted or reflected light from the sensing element to an optical detector for analysis by a processor.
- Various embodiments herein can include an active agent disposed within the outer barrier layer.
- the active agent can be any drug or bioactive agent which can serve as a useful therapeutic, prophylactic, or even diagnostic agent when released into the patient.
- bioactive agents include, but are not limited to, the following: an anti-inflammatory; anti-proliferative; anti-arrhythmic; anti-migratory; anti-neoplastic; antibiotic; anti-restenotic; anti-coagulation; anti-infectives; anti-oxidants; anti-macrophagic agents (e.g., bisphosphonates); anti-clotting (e.g., heparin, coumadin, aspirin); anti-thrombogenic; immunosuppressive agents; an agent that promotes healing; steroids (e.g., a glucocorticosteroid)); and combinations thereof.
- Suitable active agents for use with the embodiments herein can specifically include, but are not limited to anti-inflammatory agents.
- suitable anti-inflammatory agents can include steroids generally and, in specific, corticosteroids.
- the anti-inflammatory agent can include ketorolac, dexamethasone, hydrocortisone, prednisolone, methylprednisolone, indomethacin, diclofenac, ketoprofen, piroxicam, metamizol magnesium and the like.
- anti-inflammatory agents can be configured to be eluted shortly after implantation of the device.
- suitable active agents can also include angiogenic agents, to promote the in-growth of capillaries.
- angiogenic agents can be configured to be eluted at a later time (e.g., following elution of an anti-inflammatory at an earlier point in time) to promote the ingrowth of capillaries to the chemical sensor.
- suitable angiogenic agents can include growth factors such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), and the like.
- VEGF vascular endothelial growth factor
- FGF fibroblast growth factor
- PDGF platelet-derived growth factor
- the additional active agents can include immobilized heparin to prevent blot clot formation.
- Active agents herein can be in various forms including in a solution, as a suspension, as a particulate, or the like.
- the phrase “configured” describes a system, apparatus, or other structure that is constructed or configured to perform a particular task or adopt a particular configuration to.
- the phrase “configured” can be used interchangeably with other similar phrases such as arranged and configured, constructed and arranged, constructed, manufactured and arranged, and the like.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
Description
- This application claims the benefit of China Patent Application No. 201711052948.1, filed Oct. 31, 2017, the content of which is herein incorporated by reference in its entirety.
- Embodiments herein relate to implantable chemical sensors for detecting a physiological analyte and medical devices including the same.
- Medical professionals frequently need to evaluate chemical analyte concentrations of a patient when assessing the patient's condition and/or diagnosing a problem. However, measuring physiological concentrations of analytes, such as potassium amongst others, generally requires drawing blood from the patient. Blood draws are commonly done at a medical clinic or hospital and therefore generally require the patient to physically visit a medical facility. As a result, despite their significance, physiological analyte concentrations are frequently measured only sporadically.
- Implanted chemical sensors offer the promise of being able to gather data on analyte concentrations in real time even while a patient is away from a medical treatment facility. For example, implanted chemical sensors can measure analyte concentrations from the interstitial fluid as the analyte passes through a soft hydrophilic diffusion membrane and into a chemical sensor. The measurements can occur continuously or semi-continuously providing a far richer data set for a medical professional to evaluate.
- Embodiments herein relate to implantable chemical sensors for detecting a physiological analyte and medical devices including the same. In a first aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, an implantable medical device is included. The implantable medical device can include a chemical sensor configured to detect an ion concentration in a bodily fluid. The chemical sensor can include a sensing element. The sensing element can include an outer barrier layer forming a top, a bottom, and opposed sides of the sensing element and a structural reinforcing element contacting the outer barrier layer. The top of the outer barrier layer of the sensing element can include a polymeric matrix permeable to analytes.
- In a second aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, a structural reinforcing element can be disposed beneath, within, or on top of the top of the outer barrier layer.
- In a third aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, a structural reinforcing element can be formed of polyester, polyurethane, polyethylene, polypropylene, nylon, sintered titanium, deep reactive-ion etched silicon, sintered stainless steel, sintered silica, liquid crystal, glass, borosilicate glass, or mixtures or derivatives thereof.
- In a fourth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, a structural reinforcing element can be formed of a woven material.
- In a fifth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, a structural reinforcing element can include one or more intramural struts spanning a distance between the top and the bottom of the outer barrier layer.
- In a sixth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, the one or more intramural struts can be formed of polyester, polyurethane, polyethylene, polypropylene, nylon, sintered titanium, deep reactive-ion etched silicon, sintered stainless steel, sintered silica, liquid crystal, glass, borosilicate glass, or mixtures or derivatives thereof.
- In a seventh aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, an outer barrier layer can be formed of polyHEMA, agarose, alginates, polyvinyl alcohol, polyacrylate, collagen, PEG, gelatin, glass, borosilicate glass, or mixtures or derivatives thereof.
- In an eighth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, the implantable medical device can include an optical excitation assembly configured to illuminate the sensing element; and an optical detection assembly configured to receive light from the sensing element.
- In a ninth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, a chemical sensor can have a diameter that is greater than 1.0 mm.
- In a tenth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, a chemical sensor can be configured to detect an ion selected from the group consisting of potassium, sodium, chloride, calcium, magnesium, lithium, or hydronium.
- In an eleventh aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, an implantable medical device is included. The implantable medical device can include a chemical sensor configured to detect an ion concentration in a bodily fluid. The chemical sensor can include a sensing element. The sensing element can include an outer barrier layer forming a top, a bottom, and opposed sides of the sensing element, where the outer barrier layer defines an interior volume. The sensing element can also include a structural reinforcing element disposed within the interior volume, where the structural reinforcing element is porous.
- In a twelfth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, a structural reinforcing element can fill at least between 10% to 25% of the interior volume.
- In a thirteenth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, a structural reinforcing element can be formed of a polyester, polyurethane, polyethylene, polypropylene, nylon, sintered titanium, deep reactive-ion etched silicon, sintered stainless steel, sintered silica, liquid crystal, glass, borosilicate glass, or mixtures or derivatives thereof.
- In a fourteenth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, a structural reinforcing element can be formed of a borosilicate glass.
- In a fifteenth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, an outer barrier layer can be formed of polyHEMA, agarose, alginates, polyvinyl alcohol, polyacrylate, collagen, PEG, gelatin, glass, borosilicate glass, or mixtures or derivatives thereof.
- In a sixteenth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, an outer barrier layer can be formed of a glass.
- In a seventeenth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, an outer barrier layer can be formed of a borosilicate glass.
- In an eighteenth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, the bottom of an outer barrier layer can include a glass interface plate for coupling the sensing element to an optical excitation assembly and an optical detection assembly.
- In a nineteenth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, the top of the outer barrier layer can be formed of polyHEMA.
- In a twentieth aspect, in addition to one or more of the preceding or following aspects, or in the alternative to some aspects, a structural reinforcing element can be infused with one or more ion selective sensors.
- This summary is an overview of some of the teachings of the present application and is not intended to be an exclusive or exhaustive treatment of the present subject matter. Further details are found in the detailed description and appended claims. Other aspects will be apparent to persons skilled in the art upon reading and understanding the following detailed description and viewing the drawings that form a part thereof, each of which is not to be taken in a limiting sense. The scope herein is defined by the appended claims and their legal equivalents.
- Aspects may be more completely understood in connection with the following drawings, in which:
-
FIG. 1 is a schematic top view of an implantable medical device in accordance with the embodiments herein. -
FIG. 2 is a cross-sectional view of a chemical sensor taken along line 2-2′ ofFIG. 1 . -
FIG. 3 is a schematic plan view of a structural reinforcing element in accordance with various embodiments herein. -
FIG. 4 is a schematic plan view of a structural reinforcing element in accordance with various embodiments herein. -
FIG. 5 is a cross-sectional view of a chemical sensor in accordance with additional embodiments herein. -
FIG. 6 is a cross-sectional view of a chemical sensor in accordance with additional embodiments herein. -
FIG. 7 is a cross-sectional view of a chemical sensor in accordance with additional embodiments herein. -
FIG. 8 is a cross-sectional view of a chemical sensor in accordance with additional embodiments herein. -
FIG. 9 is a schematic top view of an implantable medical device in accordance with additional embodiments herein. -
FIG. 10 is a schematic cross-sectional view of a sensing element in accordance with additional embodiments herein. -
FIG. 11 is a schematic cross-sectional view of an implantable medical device in accordance with various embodiments herein. -
FIG. 12 is a schematic diagram of components of an implantable medical device in accordance with various embodiments herein. - While embodiments are susceptible to various modifications and alternative forms, specifics thereof have been shown by way of example and drawings, and will be described in detail. It should be understood, however, that the scope herein is not limited to the particular embodiments described. On the contrary, the intention is to cover modifications, equivalents, and alternatives falling within the spirit and scope herein.
- Implanted chemical sensors offer the promise of being able to gather data on analyte concentrations in real time even while a patient is away from a medical treatment facility.
- Highly-porous soft hydrophilic polymers are ideal materials for use with implanted chemical sensors because of their ability to permit the rapid transport of large amounts of analytes across sensor walls and thus contribute to rapid response times for sensors built using the same. However, many such materials lack desirable levels of structural integrity. Such materials are generally soft and flexible which can lead to challenges when designing sensor elements, especially as the sensors get larger. In particular, the use of such materials in a chemical sensor can resulting in undesirable deformation and/or structural failure and interference at the optical interface of the chemical sensor, which can lead to diminished response and/or loss of function of the chemical sensor.
- Embodiments herein, however, can include structural reinforcing elements that can provide structural integrity to soft hydrophilic diffusion membranes of chemical sensors. Thus, by including structural reinforcing elements, chemical sensors made using soft hydrophilic materials can maintain their structural integrity over the lifetime of the sensor.
- Referring now to
FIG. 1 , an implantable medical device (IMD) 100 is shown in accordance with the embodiments herein. TheIMD 100 can include animplantable housing 102 and aheader 104 coupled to theimplantable housing 102. Various materials can be used. However, in some embodiments, thehousing 102 can be formed of a material such as a metal, ceramic, a polymer, or a composite. Theheader 104 can be formed of various materials, but in some embodiments theheader 104 can be formed of a transparent or translucent polymer such as an epoxy material. In some embodiments theheader 104 can be hollow. In other embodiments theheader 104 can be filled with components and/or structural materials such as epoxy or another material such that it is non-hollow. - The
IMD 100 can also include achemical sensor 106 coupled to theimplantable housing 102.Chemical sensor 106 can be configured to detect an ion concentration of a bodily fluid when implanted in the body. In some embodiments, thechemical sensor 106 can be configured to detect an ion selected from the group consisting of potassium, sodium, chloride, calcium, magnesium, lithium, hydronium, hydrogen phosphate, bicarbonate, and the like. Bodily fluids can include blood, interstitial fluid, serum, lymph, serous fluid, cerebrospinal fluid, and the like. In some embodimentschemical sensor 106 can be configured to detect one or more of an electrolyte, a protein, a sugar, a hormone, a peptide, an amino acid, and a metabolic product. However, many other analytes are also contemplated herein. - It will be appreciated that
chemical sensor 106 can be positioned at any location alongIMD 100, including a location along theimplantable housing 102 and a location along theheader 104. TheIMD 100 can take on various dimensions. In a particular embodiment herein it can be approximately 2 to 3 inches in length, 0.4 to 0.6 inches wide, and 0.15 to 0.35 inches thick. However, in some embodiments, theIMD 100 can be about 0.25, 0.5, 1.0, 2.0, 3.0, 4.0, or 5.0 inches in length. In some embodiments the length can be in a range wherein any of the foregoing lengths can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound. In some embodiments, theIMD 100 can be about 0.25, 0.5, 0.75, 1.0, or 2.0 inches in width. In some embodiments the length can be in a range wherein any of the foregoing widths can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound. In some embodiments, theIMD 100 can be about 0.10, 0.25, 0.50, 0.75 or 1.0 inches thick. In some embodiments the thickness can be in a range wherein any of the foregoing thicknesses can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound. - In some embodiments, the
chemical sensor 106 can be in the shape of a circle. The diameter of thechemical sensor 106 can be about 0.5 mm, 0.75 mm, 1.0 mm, 1.5 mm, 1.75 mm, 2.0 mm, 2.5 mm, 2.75 mm, 3.0 mm, 3.25 mm, 3.5 mm, 3.75 mm, 4.0 mm, 4.5 mm, or 5.0 mm. In some embodiments the diameter can be in a range wherein any of the foregoing diameters can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound. In some embodiments, the diameter of thechemical sensor 106 is greater than or equal to 1.5 mm. Thoughchemical sensor 106 is depicted inFIG. 1 in the shape of a circle, it will be appreciated thatchemical sensor 106 can assume a variety of shapes, including but not limited to a square, a rectangle, a triangle, a trapezoid, an oval, and the like. It will also be appreciated thatIMD 100 can include one or more chemical sensors that measure the same, or different analytes. In some embodiments, one or more chemical sensors can be arranged as an array in a variety of shapes, such as, for example, a grid, a circle, a mosaic, a geometric patter, or the like. - The height (depth) of the
chemical sensor 106 can be about 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.75 mm, 1.0 mm, 1.5 mm, 1.75 mm, 2.0 mm, 2.5 mm, 2.75 mm, 3.0 mm, 3.25 mm, 3.5 mm, 3.75 mm, 4.0 mm, 4.5 mm, or 5.0 mm, 6 mm, 7 mm, 8 mm, 9 mm, or 10 mm. In some embodiments the height of thechemical sensor 106 can be in a range wherein any of the foregoing distances can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound. - Referring now to
FIG. 2 , a cross-sectional view ofchemical sensor 106 along line 2-2′ ofFIG. 1 is shown.Chemical sensor 106 can include, but not be limited to,sensing element 202,optical excitation assembly 218, andoptical detection assembly 220.FIG. 3 shows an optical chemical sensor. However, in other embodiments the chemical sensor can be a potentiometric chemical sensor. - The
sensing element 202 can include anouter barrier layer 204 formed, in full or in part, from a permeable material, such as an ion permeable polymeric matrix material, and the like. Exemplary materials for theouter barrier layer 204 are described in greater detail below.Outer barrier layer 204 can form a top 205, a bottom 210, and opposedsides interior volume 222 ofsensing element 202.Bottom 210 and opposedsides outer barrier layer 204 will be discussed in more detail below in reference toFIGS. 3-5 . Briefly, however, they can be formed of the same material as the top 205, or they can be formed from a different material. In some embodiments, at least the top 205 ofouter barrier layer 204 can be permeable to sodium ions, potassium ions, hydronium ions, creatinine, urea, and the like.Outer barrier layer 204 can also include an active agent disposed therein including, but not limited to anti-inflammatory agents, angiogenic agents, and the like. Exemplary active agents are described in greater detail below. - It will be appreciated, however, that
bottom 210 may or may not be a discrete layer. For example, in some embodiments,bottom 210 and atransparent member 216 within a recessedpan 214 of theimplantable housing 102 may be combined with different material or combined as one layer with same type of material. - The
outer barrier layer 204 can include a structural reinforcingelement 212 disposed within, on or under the outer surface of theouter barrier layer 204. For example, the structural reinforcingelement 212 can be disposed within, on top of, or beneath theouter barrier layer 204. In some embodiments, the structural reinforcingelement 212 can be disposed within, on or under the exterior surface ofopposed sides element 212 can be disposed within, on or under the outer surface ofbottom 210 of theouter barrier layer 204. In still other embodiments, the structural reinforcingelement 212 can be disposed within, on or under the outer surface of the entireouter barrier layer 204. The structural reinforcing element will be further discussed in reference toFIGS. 3-5 below. It will be appreciated that the structural reinforcing elements embodied herein can take on many shapes and forms in accordance with additional embodiments herein. - The structural reinforcing elements can come in various shapes and sizes. In some embodiments, the structural reinforcing elements can be columnar, pyramidal, frustopyramidal, conical, frustoconical, cylindrical, rectangular, and the like. In some embodiments, the base of the structural reinforcing element can have a greater width than the top of the structural reinforcing element. In some embodiments, the top of the structural reinforcing element can have a greater width than the bottom of the structural reinforcing element. In some embodiments, the top and the bottom of the structural reinforcing element can have the same width. The height of the structural reinforcing elements can be about 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.75 mm, 1.0 mm, 1.5 mm, 1.75 mm, 2.0 mm, 2.5 mm, 2.75 mm, 3.0 mm, 3.25 mm, 3.5 mm, 3.75 mm, 4.0 mm, 4.5 mm, or 5.0 mm, 6 mm, 7 mm, 8 mm, 9 mm, or 10 mm. In some embodiments the height of the structural reinforcing elements can be in a range wherein any of the foregoing diameters can serve as the upper or lower bound of the range, provided that the upper bound is greater than the lower bound.
- The structural reinforcing elements can be positioned in various places within the sensing element. In some embodiments, there can be multiple structural reinforcing elements and they can be spaced out across the sensing element (such as spaced out across the width of the chemical sensor along X and/or Y axes, wherein the depth of the chemical sensor would be the Z axis). In some embodiments, multiple structural reinforcing elements can be evenly spaced out. In some embodiments, multiple structural reinforcing elements can spaced from each other, but with a bias toward the middle of the diameter of the chemical sensor, such that a central portion (such as a central 50% of the overall diameter) has a higher density of structural reinforcing elements.
- Materials suitable for forming the structural reinforcing elements discussed herein can include, but not be limited to, porous rigid polymers, porous rigid ceramics, polyester, polyurethane, polyethylene, polypropylene, nylon, sintered titanium, deep reactive-ion etched silicon, sintered stainless steel, sintered silica, liquid crystal, glass, silica-containing glass, borosilicate glass such as but not limited to VYCOR®, or mixtures or derivatives thereof. Structural reinforcing elements will be discussed in more detail below.
- The
implantable housing 102 can include a recessedpan 214 into which thesensing element 202 fits. In some embodiments, the top of the recessedpan 214 can be substantially flush with the top of thesensing element 202. - In some embodiments,
implantable housing 102 can define an aperture occluded by atransparent member 216. Thetransparent member 216 can be a glass (including but not limited to borosilicate glasses), a polymer or other transparent material. The aperture can be disposed at the bottom of the recessedpan 214. The aperture can provide an interface allowing for optical communication betweensensing element 202 and theoptical excitation 218 andoptical detection 220 assemblies. In some embodiments, thebottom 210 of theouter barrier layer 204 can be combined with thetransparent member 216.Bottom 210 andtransparent member 216 may be combined with different material or combined as one layer with same type of material. - It will be appreciated that
outer barrier layer 204, or portions thereof such as the bottom 210, can be made from a transparent polymer matrix material to allow for optical communication between thesensing element 202 andoptical excitation 218 andoptical detection 220 assemblies. - The
optical excitation assembly 218 can be configured to illuminate thesensing element 202.Optical excitation assembly 218 can include a light source such as a light emitting diode (LED), vertical-cavity surface-emitting lasers (VCSELs), electroluminescent (EL) devices, and the like.Optical detection assembly 220 can include a component selected from the group consisting of a photodiode, a phototransistor, a charge-coupled device (CCD), a junction field effect transistor (JFET) optical sensor, a complementary metal-oxide semiconductor (CMOS) optical sensor, an integrated photo detector integrated circuit, a light to voltage converter, and the like.Optical excitation 218 andoptical detection 220 assemblies are discussed in further detail below. - Referring now to
FIG. 3 , a schematic plan view is shown of a structural reinforcingelement 212 in accordance with various embodiments herein. The structural reinforcingelement 212 can take on many different shapes including but not limited to a square, a rectangle, a triangle, a trapezoid, an oval, and the like. - In the view of
FIG. 3 , the structural reinforcingelement 212 is solid, but porous. However, it will be appreciated that in some embodiments, the structural reinforcingelement 212 can be formed of a non-porous material. Further, in some embodiments, the structural reinforcing element can include one or more apertures disposed therein. Referring now toFIG. 4 a schematic plan view is shown of a structural reinforcingelement 212 in accordance with various embodiments herein. As can be seen, the structural reinforcingelement 212 includesapertures 402. - Referring now to
FIGS. 5-7 ,sensing element 202 is shown in accordance with various embodiments herein. As discussed above with reference toFIG. 2 ,sensing element 202 can include anouter barrier layer 204.Outer barrier layer 204 can form a top 205, a bottom 210, and opposedsides interior volume 222 ofsensing element 202.Outer barrier layer 204 can also include a structural reinforcingelement 212. - For example,
FIG. 5 shows asensing element 202 having anouter barrier layer 204, the outer barrier layer including a top 205, a bottom 210, and opposingsides outer barrier layer 204 are discussed further below. - The
sensing element 202 can include one or more intramural struts 306 spanning a distance between the top 205 and thebottom 210 of theouter barrier layer 204. The one or moreintramural struts 506 can include a structural reinforcingelement 212 disposed within, on or under the outer surface of theintramural struts 506. Materials suitable for forming the structural reinforcingelement 212 of the one or moreintramural struts 506 can include, but not be limited to rigid porous polymers, rigid porous ceramics, polyester, polyurethane, polyethylene, polypropylene, nylon, sintered titanium, deep reactive-ion etched silicon, sintered stainless steel, sintered silica, liquid crystal, glass, borosilicate glass, or mixtures or derivatives thereof. - In some embodiments, the intramural struts 306 can have a larger size or diameter on the side that contacts the bottom 210 in comparison to the size of the intramural struts that contacts the top 205. However, the reverse may also be true, such as shown in
FIG. 6 described below. In some embodiments, the intramural struts 306 can be circular, oval, square, or polygonal in cross-section. The length of the struts can depend on the size of the sensing element, but in some embodiments can be 0.1 mm, 0.2 mm, 0.3 mm, 0.4 mm, 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1 mm, 2 mm, 3 mm, 4 mm, 5 mm, 7 mm, 9 mm, 11 mm, 13 mm, 15 mm, 20 mm, or 30 mm; or can fall within a range between any of the foregoing distances. The number of struts can vary. The number of struts used can be 1, 2, 3, 4, 5, 7, 9, 11, 13, 15, 20, 25, 30, 40, 50, 60, 80, 100 or more. In some embodiments, the number of struts can fall within a range between any of the foregoing. - The sensing element(s) 202 embodied herein can include an
interior volume 222 and can also include disposed therein various indicator beads for detecting an ion concentration of a bodily fluid when implanted in the body. For example,FIG. 5 shows afirst indicator bead 502 and asecond indicator bead 504. The first andsecond indicator beads outer barrier layer 204, and where present, the structural reinforcingelement 212, and onto and/or into first andsecond indicator beads - In some embodiments, the
first indicator beads 502 can be segregated to one side of theinterior volume 222, with or without an interior divider. In some embodiments, thesecond indicator beads 504 can be segregated to a different side of the interior volume than thefirst indicator beads 502. In some embodiments, thefirst indicator beads 502 andsecond indicator beads 504 can be designed to detect the same analyte. In some embodiments, thefirst indicator beads 502 andsecond indicator beads 504 can be designed to detect the different analytes. In some embodiments thefirst indicator beads 502 and thesecond indicator beads 504 can be separated out by having two individual outer barrier layers 204. For example, instead of a singleouter barrier layer 204, there can be two discrete outer barrier layers 204 with each surrounding a separate set of indicator beads. In various embodiments, the two sets of beads can be spaced out by a certain distance, such as at least about 0.1, 0.2, 0.3, 0.4, 0.5, 1, 2, 3, 5, 10 or 15 millimeters and less than 100, 70, 50, 40, 30, or 20 millimeters. - Beyond diffusion through the top 205, in some embodiments additional diffusion of physiological analytes is also possible through
bottom 210, opposingsides element 212. - While
FIG. 5 shows discrete indicator beads, it will be appreciated that the indicator components can also exist in other forms such as a single larger combined mass, an infusion, or the like, as will be discussed with respect toFIGS. 7 and 8 . - In some embodiments, the sensing element(s) 202 embodied herein can include an
aqueous solution 508 disposed within theinterior volume 222. In some embodiments, theaqueous solution 508 can include potassium ions at a concentration of about 3.0 to about 6.0 mmol/L. In some embodiments, theaqueous solution 508 can include potassium ions at a concentration of about 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, or 8.0 mmol/L. In some embodiments, the concentration of potassium ions in theaqueous solution 508 can be in a range between any of the foregoing multiples provided that the upper bound of the range is greater than the lower bound of the range. In some embodiments, theaqueous solution 508 can surround the exterior ofsensing element 202 during packaging and prior to use, as discussed below in reference toFIG. 10 . - In
FIGS. 5 and 6 ,sensing element 202 is shown having anouter barrier layer 204, the outer barrier layer including a top 205, a bottom 210, and opposingsides outer barrier layer 204 are discussed further below. -
FIG. 5 shows a structural reinforcingelement 212 disposed within theinterior volume 222 ofsensing element 202. In the embodiment shown inFIG. 6 , the structural reinforcingelement 212 can be created from a porous material. In some embodiments, the structural reinforcingelement 212 can fill at least 5%, 10%, 15%, 20%, 25%, 30%, 40%, or 50% of theinterior volume 222 ofsensing element 202. It will be appreciated that the structural reinforcingelement 212 can fill an interior volume falling within a range, wherein any of the forgoing percentages can serve as the lower or upper bound of the range, provided that the lower bound of the range is a value less than the upper bound of the range. In some embodiments, the structural reinforcingelement 212 disposed withininterior volume 222 can be infused with one or more ion selective sensors, which are described more fully below. -
FIG. 6 shows a structural reinforcingelement 212 disposed within theinterior volume 222 ofsensing element 202. In the embodiment shown inFIG. 6 , the structural reinforcingelement 212 can be created from a porous material. In some embodiments, the structural reinforcingelement 212 can fill at least 5%, 10%, 15%, 20%, 25%, 30%, 40%, or 50% of theinterior volume 222 ofsensing element 202. In some embodiments, the structural reinforcingelement 212 disposed withininterior volume 222 can be infused with one or more ion selective sensors, which are described more fully below. The structural reinforcingelement 212 can include one or moreintramural struts 506. - It will be appreciated that some portions of the
outer barrier layer 204 can be formed of a different material, while in other embodiments the entireouter barrier layer 204 can be formed of the same material.FIG. 7 , shows asensing element 202 having anouter barrier layer 204 where the top 205, and opposingsides bottom 210 ofouter barrier layer 204 can be formed of a transparent material to couple thesensing element 202 to theoptical excitation 218 andoptical detection 220 assemblies. Coupling thesensing element 202 to theoptical excitation 218 andoptical detection 220 assemblies can facilitate optical communication between the two structures. - However, in some embodiments, the bottom can be formed from a different material than the outer barrier layer. Referring now to
FIG. 8 , another cross-sectional view of a chemical sensor is shown in accordance with some embodiments. In some embodiments, the bottom 210 can be formed from a glass, such as a borosilicate glass. In some embodiments, the bottom 210 can be formed from transparent polymeric materials. In some embodiments, bottom 210 can be fused to an implantable housing at the interface with a transparent member, as discussed above. - Referring now to
FIG. 9 , an implantablemedical device 900 is shown in accordance with the embodiments herein. Implantablemedical device 900 can include animplantable housing 102 coupled to aheader 104. Thechemical sensor 106 is shown coupled to theheader 104. It will be appreciated that more than one chemical sensor can be included in theheader 104 ofmedical device 900. - In some embodiments, it may be desirable to ship the chemical sensor and/or medical device with the sensor pre-wetted (e.g., bathed in an aqueous solution). Referring now to
FIG. 10 , an embodiment ofchemical sensor 106 is shown having aseal 1002 over the top 205 ofsensing element 202.Seal 1002 can provide a tight seal between the external environment and thechemical sensor 106 when packaged. For example,seal 1002 can provide an effective barrier to keep aqueous solution 308 within recessedpan 214 such that thesensing element 202 can be constantly bathed in aqueous solution 308 prior to implant. - In some embodiments, the aqueous solution 308 present in recessed
pan 214 can also include potassium ions at a concentration of about 3.0 to about 6.0 mmol/L. In some embodiments, the aqueous solution 308 can include potassium ions at a concentration of about 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0, or 8.0 mmol/L. In some embodiments, the concentration of potassium ions in the aqueous solution 308 can be in a range between any of the foregoing amounts provided that the upper bound of the range is greater than the lower bound of the range. -
Seal 1002 can be removed from thechemical sensor 106 by a medical professional just prior to implantation. In some embodiments,seal 1002 can be non-porous to the passage of aqueous solutions. In some embodiments,seal 1002 can be made from a polymer such as polyethylene terephthalate (PET), polytetrafluoroethylene (PTFE), polyethylene, polystyrene, and the like. In some embodiments, theseal 1002 can be made from a foil, such as a metal foil. In some embodiments, theseal 1002 can be made from a radiopaque material. - Referring now to
FIG. 11 , a schematic cross-sectional view ofIMD 100 is shown in accordance with various embodiments herein. TheIMD 100 can includeimplantable housing 102. Theimplantable housing 102 ofIMD 100 can include various materials such as metals, polymers, ceramics, and the like. In some embodiments, theimplantable housing 102 can be a single integrated unit. In other embodiments, theimplantable housing 102 can includeimplantable housing 102 andepoxy header 104, as discussed above. In some embodiments, theimplantable housing 102, or one or more portions thereof, can be formed of titanium. In some embodiments, one or more segments of theimplantable housing 102 can be hermetically sealed. -
Implantable housing 102 can define an interior volume 804 that in some embodiments is hermetically sealed off from thearea 1106 outside ofIMD 100. TheIMD 100 can includecircuitry 1108.Circuitry 1108 can include various components, such ascomponents - A
telemetry interface 1122 can be provided for communicating with external devices such as a programmer, a home-based unit, and/or a mobile unit (e.g., a cellular phone, portable computer, etc.). In someembodiments telemetry interface 1122 can be provided for communicating with implanted devices such as a therapy delivery device (e.g. a pacemaker, cardioverter-defibrillator) or monitoring-only device (e.g. an implantable loop recorder). In some embodiments, the circuitry can be implemented remotely, via either near-field, far-field, conducted, intra-body or extracorporeal communication, from instructions executing on any of the external or the implanted devices, etc. In some embodiments, thetelemetry interface 1122 can be located withinimplantable housing 102. In some embodiments, thetelemetry interface 1122 can be located inheader 104. - The
optical excitation 218 andoptical detection 220 assemblies of thechemical sensor 106 can be in electrical communication with thecircuitry 1108 within theinterior volume 1104. In some embodiments, thecontrol circuitry 1108 is configured to selectively activate theoptical excitation 218 andoptical detection 220 assemblies of thechemical sensor 106. - Referring now to
FIG. 12 , a schematic diagram of components ofIMD 100 in accordance with various embodiments herein. It will be appreciated that some embodiments can include additional elements beyond those shown inFIG. 12 . In addition, some embodiments may lack some elements shown inFIG. 12 .IMD 100 can gather information through one or more sensing channels. Amicroprocessor 1202 can communicate with amemory 1204 via a bidirectional data bus. Thememory 1204 can include read only memory (ROM) or random access memory (RAM) for program storage and RAM for data storage, or any combination thereof. The implantable medical device can also include one or morechemical sensors 106 and one or more chemicalsensor channel interfaces 1206 which can communicate with a port ofmicroprocessor 1202. The chemicalsensor channel interface 1206 can include various components such as analog-to-digital converters for digitizing signal inputs, sensing amplifiers, registers which can be written to by the control circuitry in order to adjust the gain and threshold values for the sensing amplifiers, source drivers, modulators, demodulators, multiplexers, and the like. Atelemetry interface 1122 is also provided for communicating with external devices such as a programmer, a home-based unit, and/or a mobile unit (e.g., a cellular phone, portable computer, etc.), implanted devices such as a pacemaker, cardioverter-defibrillator, loop recorder, and the like. - As referenced above, the outer barrier layer of the sensing element can be formed of a permeable material. In some embodiments, the outer barrier layer can be formed from an ion-permeable polymeric matrix material. Suitable polymers for use as the ion-permeable polymeric matrix material can include, but are not limited to polymers forming a hydrogel. Hydrogels herein can include homopolymeric hydrogels, copolymeric hydrogels, and multipolymer interpenetrating polymeric hydrogels. Hydrogels herein can specifically include nonionic hydrogels.
- In some embodiments, hydrogels herein can be prepared from polymerization of various monomers or macromers including one or more of poly 2-hydroxyethyl methacrylate (polyHEMA), 2-hydroxypropyl methacrylate (HPMA), acrylamide, acrylic acid, N-isopropylacrylamide (NIPAm), methoxyl polyethylene glycol monoacrylate (PEGMA), and the like. In some embodiments, polymers can include, but are not limited to polyhydroxyethyl methacrylate (HEMA), cellulose, polyvinyl alcohol, polyacrylate, dextran, polyacrylamides, polyhydroxyalkyl acrylates, polyvinyl pyrrolidones, and mixtures and copolymers thereof. In some embodiments, suitable polymers for use with the ion-permeable polymeric matrix described herein include those that are transparent.
- In yet other embodiments, the outer barrier layer can be formed from porous materials such as, agarose, alginates, collagen, polyethylene glycol (PEG), gelatin, glass, borosilicate glass, or mixtures or derivatives thereof. In some embodiments, the outer barrier layer is formed from glass. In some embodiments, the outer barrier layer is formed from borosilicate glass.
- As discussed above, the outer barrier layer of the sensing element can include a structural reinforcing element disposed within the outer barrier layer. In other embodiments, the structural reinforcing element can be disposed on the outer or inner surfaces of the outer barrier layer. In some embodiments, the structural reinforcing element can be formed from an ion-permeable material. In other embodiments, the structural reinforcing element can be formed form a non-permeable material.
- Materials suitable for use with the structural reinforcing elements herein can include polyesters, such as polyethylene terephthalate (e.g., Dacron®); polyurethanes, including but not limited to Tecothane® aromatic polyether-based thermoplastic polyurethanes (TPUs); polyethylene; polypropylene; nylon; silk; polymethylmethacrylate (PMMA); sintered titanium; deep reactive-ion etched silicon; sintered stainless steel; sintered silica; liquid crystal; alumina; ceramic; glass; borosilicate glass; and the like.
- In some embodiments, the structural reinforcing element can exhibit a stiffness greater than the material of the outer barrier. In some embodiments, the structural reinforcing element can be about 10, 20, 30, 40, 50, 60, 80, 100, 150, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1500, 2000, or 2500 percent stiffer than the outer barrier layer material. In some embodiments, the structural reinforcing element can greater than 3000 percent stiffer than the outer barrier layer material.
- In some embodiments, the structural reinforcing element can exhibit rigidity greater than the material of the outer barrier. In some embodiments, the structural reinforcing element can be about 10, 20, 30, 40, 50, 60, 80, 100, 150, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1500, 2000, or 2500 percent more rigid than the outer barrier layer material.
- In some embodiments, the structural reinforcing element can exhibit greater tensile strength than the material of the outer barrier. In some embodiments, the structural reinforcing element can exhibit about 10, 20, 30, 40, 50, 60, 80, 100, 150, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1500, 2000, or 2500 percent more tensile strength than the outer barrier layer material.
- In some embodiments, the structural reinforcing element can include a woven material. In some embodiments, the structural reinforcing element can include a woven material made from an ion-permeable polymeric material. In some embodiments, the structural reinforcing element can include a woven material made from a non-permeable material. In some embodiments, the woven material can include a uniform weave pattern of fibers throughout the entirety of the structural reinforcing element. In other embodiments, the woven material can include a non-uniform weave pattern of fibers throughout the entirety of the structural reinforcing element. In some embodiments, the woven material can include oriented weave patterns. In other embodiments, the structural reinforcing element can include a non-woven material having a non-uniform weave pattern of fibers throughout the entirety of the structural reinforcing element. An example of a non-woven material is Tyvek®, which is made from high-density polyethylene fibers. In some embodiments, the structural reinforcing element can include an electrospun polymeric material. In some embodiments, the electrospun polymeric material can include a randomly woven polymeric material.
- In yet other embodiments, the structural reinforcing element can be formed into a one-piece molded unit that can be infused with one or more ion selective sensors.
- In accordance with the embodiments herein, sensing
elements 202 can include one or more ion selective sensors included within one or more types of indicator beads, or infused within the structural reinforcing elements as described herein. Ion selective sensors may either rely on surface phenomena or on concentration changes inside the bulk of a phase. Ion selective sensors can include optical sensors, including both non-carrier optical sensors and carrier-based optical sensors, and ion-selective electrodes (ISEs). In some embodiments, the ion selective sensor is fluorimetric, and can include a complexing moiety and a fluorescing moiety. Fluorimetric ion selective sensors can exhibit differential fluorescent intensity based upon the complexing of an analyte to a complexing moiety. In some embodiments, the ion selective sensor can be colorimetric, and can include a complexing moiety and a colorimetric moiety. Colorimetric ion selective sensors can exhibit differential light absorbance based upon the complexing of an analyte to a complexing moiety. - In some embodiments, the ion selective sensor comprises a non-carrier or carrier-based fluorescent or colorimetric ionophoric composition that comprises a complexing moiety for reversibly binding an ion to be analyzed, and a fluorescing or colorimetric moiety that changes its optical properties as the complexing agent binds or releases the ion. The complexing agents of the invention can optionally be appended with one or more organic substituents chosen to confer desired properties useful in formulating the ion sensing composition. By way of example, the substituents can be selected to stabilize the complexing agent with respect to leaching into the solution to be sensed, for example, by incorporating a hydrophobic or polymeric tail or by providing a means for covalent attachment of the complexing agent to a polymer support within the ion selective sensor.
- In some embodiments, the sensing element can include ion selective sensors such as an ionophore or a fluoroionophore. Suitable ionophores for use with the embodiments herein can include, but not be limited to, sodium specific ionophores, potassium specific ionophores, calcium specific ionophores, magnesium specific ionophores, and lithium specific ionophores. Suitable fluoroionophores for use with the embodiments herein can include, but not be limited to, lithium specific fluoroionophores, sodium specific fluoroionophores, and potassium specific fluoroionophores.
- Exemplary ion selective sensors and methods for their use are disclosed in commonly assigned U.S. Pat. No. 7,809,441, the contents of which is herein incorporated by reference in its entirety.
- In some embodiments, the
optical excitation assembly 218 can include solid state light sources such as GaAs, GaAlAs, GaAlAsP, GaAlP, GaAsP, GaP, GaN, InGaAlP, InGaN, ZnSe, or SiC light emitting diodes or laser diodes that excite the sensing element(s) 202 at or near the wavelength of maximum absorption for a time sufficient to emit a return signal. However, it will be understood that in some embodiments the wavelength of maximum absorption/reflection varies as a function of concentration in the colorimetric sensor. - In some embodiments, the
optical excitation assembly 218 can include other light emitting components including incandescent components. In some embodiments, theoptical excitation assembly 218 can include a waveguide. Theoptical excitation assembly 218 can also include one or more bandpass filters, high pass filter, low pass filter, antireflection elements, and/or focusing optics. - In some embodiments, the
optical excitation assembly 218 can include a plurality of LEDs with bandpass filters, each of the LED-filter combinations emitting at a different center frequency. According to various embodiments, the LEDs can operate at different center-frequencies, sequentially turning on and off during a measurement, illuminating thesensing element 202. As multiple different center-frequency measurements are made sequentially, a single unfiltered detector can be used in some embodiments. However, in some embodiments, a polychromatic source can be used with multiple detectors that are each bandpass filtered to a particular center frequency. - The
sensing element 202 can include one or more types of indicator beads having embedded therein various types of ion selective sensors, described below. Physiological analytes of interest can diffuse into and out of thesensing element 202 and bind with an ion selective sensor to result in a fluorimetric or colorimetric response. Reference analytes can similarly diffuse into and out of thesensing element 202 and serve as a control sample. Exemplary ion selective sensors are described more fully below. - The
optical detection assembly 220 can be configured to receive light from thesensing element 202. In an embodiment, theoptical detection assembly 220 can include a component to receive light. By way of example, in some embodiments, theoptical detection assembly 220 can include a charge-coupled device (CCD). In other embodiments, theoptical detection assembly 220 can include a photodiode, a junction field effect transistor (JFET) type optical sensor, or a complementary metal-oxide semiconductor (CMOS) type optical sensor. In some embodiments, theoptical detection assembly 220 can include an array of optical sensing components. In some embodiments, theoptical detection assembly 220 can include a waveguide. Theoptical detection assembly 220 can also include one or more bandpass filters and/or focusing optics. In some embodiments, theoptical detection assembly 220 can include one or more photodiode detectors, each with an optical bandpass filter tuned to a specific wavelength range. - The optical excitation and detection assemblies, 218 and 220, respectively, can be integrated using bifurcated fiber-optics that direct excitation light from a light source to one or
more sensing elements 202, or simultaneously to sensing element(s) 202 and a reference channel. Return fibers can direct emission signals from the sensing element(s) 202 and the reference channels to one or moreoptical detection assemblies 220 for analysis by a processor, such as a microprocessor. In some embodiments, the optical excitation and detection assemblies are integrated using a beam-splitter assembly and focusing optical lenses that direct excitation light from a light source to the sensing element and direct emitted or reflected light from the sensing element to an optical detector for analysis by a processor. - Various embodiments herein can include an active agent disposed within the outer barrier layer. The active agent can be any drug or bioactive agent which can serve as a useful therapeutic, prophylactic, or even diagnostic agent when released into the patient. Exemplary bioactive agents include, but are not limited to, the following: an anti-inflammatory; anti-proliferative; anti-arrhythmic; anti-migratory; anti-neoplastic; antibiotic; anti-restenotic; anti-coagulation; anti-infectives; anti-oxidants; anti-macrophagic agents (e.g., bisphosphonates); anti-clotting (e.g., heparin, coumadin, aspirin); anti-thrombogenic; immunosuppressive agents; an agent that promotes healing; steroids (e.g., a glucocorticosteroid)); and combinations thereof.
- Suitable active agents for use with the embodiments herein can specifically include, but are not limited to anti-inflammatory agents. In some embodiments, suitable anti-inflammatory agents can include steroids generally and, in specific, corticosteroids. In some embodiments, the anti-inflammatory agent can include ketorolac, dexamethasone, hydrocortisone, prednisolone, methylprednisolone, indomethacin, diclofenac, ketoprofen, piroxicam, metamizol magnesium and the like. In some embodiments, anti-inflammatory agents can be configured to be eluted shortly after implantation of the device.
- In some embodiments, suitable active agents can also include angiogenic agents, to promote the in-growth of capillaries. In some embodiments, angiogenic agents can be configured to be eluted at a later time (e.g., following elution of an anti-inflammatory at an earlier point in time) to promote the ingrowth of capillaries to the chemical sensor.
- In some embodiments, suitable angiogenic agents can include growth factors such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), and the like. In some embodiments, the additional active agents can include immobilized heparin to prevent blot clot formation.
- Active agents herein can be in various forms including in a solution, as a suspension, as a particulate, or the like.
- The embodiments described herein are not intended to be exhaustive or to limit the invention to the precise forms disclosed in the following detailed description. Rather, the embodiments are chosen and described so that others skilled in the art can appreciate and understand the principles and practices. Aspects have been described with reference to various specific and preferred embodiments and techniques. However, it should be understood that many variations and modifications may be made while remaining within the spirit and scope herein.
- It should be noted that, as used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to a composition containing “a compound” includes a mixture of two or more compounds. It should also be noted that the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
- It should also be noted that, as used in this specification and the appended claims, the phrase “configured” describes a system, apparatus, or other structure that is constructed or configured to perform a particular task or adopt a particular configuration to. The phrase “configured” can be used interchangeably with other similar phrases such as arranged and configured, constructed and arranged, constructed, manufactured and arranged, and the like.
- All publications and patent applications in this specification are indicative of the level of ordinary skill in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated by reference. Nothing herein is to be construed as an admission that the inventors are not entitled to antedate any publication and/or patent, including any publication and/or patent cited herein.
Claims (20)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18202201.2A EP3517033A1 (en) | 2017-10-31 | 2018-10-24 | Structural diffusion membranes for chemical sensors |
US18/582,747 US20240268718A1 (en) | 2017-10-31 | 2024-02-21 | Structural diffusion membranes for chemical sensors |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711052948.1A CN109717876B (en) | 2017-10-31 | 2017-10-31 | Structural diffusion membrane for chemical sensors |
CN201711052948.1 | 2017-10-31 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/582,747 Continuation US20240268718A1 (en) | 2017-10-31 | 2024-02-21 | Structural diffusion membranes for chemical sensors |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190125228A1 true US20190125228A1 (en) | 2019-05-02 |
Family
ID=66245288
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/130,638 Abandoned US20190125228A1 (en) | 2017-10-31 | 2018-09-13 | Structural diffusion membranes for chemical sensors |
US18/582,747 Pending US20240268718A1 (en) | 2017-10-31 | 2024-02-21 | Structural diffusion membranes for chemical sensors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/582,747 Pending US20240268718A1 (en) | 2017-10-31 | 2024-02-21 | Structural diffusion membranes for chemical sensors |
Country Status (3)
Country | Link |
---|---|
US (2) | US20190125228A1 (en) |
EP (1) | EP3517033A1 (en) |
CN (1) | CN109717876B (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10952621B2 (en) | 2017-12-05 | 2021-03-23 | Cardiac Pacemakers, Inc. | Multimodal analyte sensor optoelectronic interface |
US11089983B2 (en) | 2017-12-01 | 2021-08-17 | Cardiac Pacemakers, Inc. | Multimodal analyte sensors for medical devices |
US11129557B2 (en) | 2017-05-31 | 2021-09-28 | Cardiac Pacemakers, Inc. | Implantable medical device with chemical sensor |
US11439304B2 (en) | 2017-08-10 | 2022-09-13 | Cardiac Pacemakers, Inc. | Systems and methods including electrolyte sensor fusion |
US11571151B2 (en) | 2017-08-23 | 2023-02-07 | Cardiac Pacemakers, Inc. | Implantable chemical sensor with staged activation |
US12004853B2 (en) | 2017-07-26 | 2024-06-11 | Cardiac Pacemakers, Inc. | Systems and methods for disambiguation of posture |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5607644A (en) * | 1993-06-10 | 1997-03-04 | Optical Sensors Incorporated | Optical sensor for the measurement of pH in a fluid, and related sensing compositions and methods |
US7181261B2 (en) * | 2000-05-15 | 2007-02-20 | Silver James H | Implantable, retrievable, thrombus minimizing sensors |
US6702857B2 (en) * | 2001-07-27 | 2004-03-09 | Dexcom, Inc. | Membrane for use with implantable devices |
US6751491B2 (en) * | 2001-09-01 | 2004-06-15 | M Biotech Inc | Analyte measuring biosensor chip using image scanning system |
EP1604697A1 (en) * | 2004-06-09 | 2005-12-14 | J.A.C.C. GmbH | Implantable device |
ES2326286T3 (en) * | 2005-12-19 | 2009-10-06 | F. Hoffmann-La Roche Ag | SANDWICH TYPE SENSOR TO DETERMINE THE CONCENTRATION OF AN ANALYTE. |
US7809441B2 (en) | 2006-05-17 | 2010-10-05 | Cardiac Pacemakers, Inc. | Implantable medical device with chemical sensor and related methods |
US7805174B2 (en) * | 2007-09-18 | 2010-09-28 | Cardiac Pacemakers, Inc. | Implantable electro-optical sensor |
US20090124875A1 (en) * | 2007-11-14 | 2009-05-14 | Cardiac Pacemakers, Inc. | Implantable Creatinine Sensor and Related Methods |
EP2174586B1 (en) * | 2008-10-02 | 2014-12-10 | EyeSense AG | Implantable sensor element |
WO2010073249A1 (en) * | 2008-12-24 | 2010-07-01 | Glusense, Ltd. | Implantable optical glucose sensing |
US9649056B2 (en) * | 2011-12-29 | 2017-05-16 | Optica, Inc. | Analyte sensor with extended range of detection |
AU2014274784B2 (en) * | 2013-06-06 | 2018-12-06 | Profusa, Inc. | Apparatus and methods for detecting optical signals from implanted sensors |
DE102014112972A1 (en) * | 2013-09-12 | 2015-03-12 | Endress + Hauser Conducta Gesellschaft für Mess- und Regeltechnik mbH + Co. KG | Measuring diaphragm for an optochemical or amperometric sensor |
CN106535757B (en) * | 2014-07-29 | 2019-06-21 | 心脏起搏器股份公司 | It is implanted into lead analysis system and method |
-
2017
- 2017-10-31 CN CN201711052948.1A patent/CN109717876B/en active Active
-
2018
- 2018-09-13 US US16/130,638 patent/US20190125228A1/en not_active Abandoned
- 2018-10-24 EP EP18202201.2A patent/EP3517033A1/en active Pending
-
2024
- 2024-02-21 US US18/582,747 patent/US20240268718A1/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11129557B2 (en) | 2017-05-31 | 2021-09-28 | Cardiac Pacemakers, Inc. | Implantable medical device with chemical sensor |
US12004853B2 (en) | 2017-07-26 | 2024-06-11 | Cardiac Pacemakers, Inc. | Systems and methods for disambiguation of posture |
US11439304B2 (en) | 2017-08-10 | 2022-09-13 | Cardiac Pacemakers, Inc. | Systems and methods including electrolyte sensor fusion |
US11571151B2 (en) | 2017-08-23 | 2023-02-07 | Cardiac Pacemakers, Inc. | Implantable chemical sensor with staged activation |
US11089983B2 (en) | 2017-12-01 | 2021-08-17 | Cardiac Pacemakers, Inc. | Multimodal analyte sensors for medical devices |
US10952621B2 (en) | 2017-12-05 | 2021-03-23 | Cardiac Pacemakers, Inc. | Multimodal analyte sensor optoelectronic interface |
Also Published As
Publication number | Publication date |
---|---|
EP3517033A1 (en) | 2019-07-31 |
US20240268718A1 (en) | 2024-08-15 |
CN109717876A (en) | 2019-05-07 |
CN109717876B (en) | 2023-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240268718A1 (en) | Structural diffusion membranes for chemical sensors | |
US11129557B2 (en) | Implantable medical device with chemical sensor | |
US10952621B2 (en) | Multimodal analyte sensor optoelectronic interface | |
EP3672486B1 (en) | Implantable chemical sensor with staged activation | |
US11089983B2 (en) | Multimodal analyte sensors for medical devices | |
US7964390B2 (en) | Sensor system | |
US7809441B2 (en) | Implantable medical device with chemical sensor and related methods | |
AU2013370204B2 (en) | Analyte permeable membrane systems for oxidative and optical stability | |
EP3427661B1 (en) | Drug elution for in vivo protection of bio-sensing analytes | |
EP3492014B1 (en) | Multimodal analyte sensors for medical devices | |
US20090124875A1 (en) | Implantable Creatinine Sensor and Related Methods | |
US20220133178A1 (en) | Fibrous cover layer for medical devices | |
US20220133234A1 (en) | Integrated thermo-photonic chemical sensor | |
WO2005074612A9 (en) | Sensor system | |
EP4236794A2 (en) | Rolled multilayer chemical sensing elements and devices and system including the same | |
US11109779B2 (en) | Chemical modification of analyte permeable membrane for enhanced oxidative stability | |
WO2014186727A1 (en) | Opacity consistent polymer graft for optical sensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: CARDIAC PACEMAKERS, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KANE, MICHAEL J.;LI, YINGBO;GORDON, JACK;SIGNING DATES FROM 20180625 TO 20180802;REEL/FRAME:047340/0594 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |